Rare diseases
Investigational molecules
Locations
Back to Spain7 clinical trials in Ponferrada, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)SpainEfficacy and safety of 6‑grass pollen polymerized extracts 30,000 TU/mL and 10,000 TU/mL in adults with grass pollen‑induced allergic rhinitis/rhinoconjunctivitis, with or without mild‑to‑moderate asthma
SpainStudy on the Effectiveness of N-Acetylcysteine and Methylprednisolone for Patients with Severe Acute Alcoholic Hepatitis
SpainStudy of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups
SpainStudy on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder
SpainStudy on Aticaprant and Antidepressant for Preventing Relapse in Adults with Major Depressive Disorder and Anhedonia
SpainStudy Comparing Trelegy with LABA-LAMA Drug Combination for Improving COPD Control in High-Risk Patients
SpainThe busiest research cities in the country
What the registry says about research in the country
Investigating innovative treatments for severe acute alcoholic hepatitis, combining conventional therapy with N-acetylcysteine to improve patient outcomes and reduce mortality rates.
Studies focus on enhancing therapeutic effectiveness in critical liver conditions.
Advanced research into Chronic Obstructive Pulmonary Disease management, evaluating the effectiveness of triple therapy versus dual bronchodilator combinations for improved clinical control.
Exploring innovative therapeutic approaches for better breathing outcomes.
Groundbreaking research on osteosynthesis material infections, examining optimal antimicrobial treatment durations following long bone fracture repairs.
Developing evidence-based protocols for post-surgical infection treatment.
Innovative trials focusing on Major Depressive Disorder treatment, particularly investigating new adjunctive therapies for patients with moderate-to-severe anhedonia.
Advancing therapeutic options for complex psychiatric conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
